177 related articles for article (PubMed ID: 11153979)
41. A high risk of life-threatening infectious complications in mycophenolate mofetil treatment for acute or chronic graft-versus-host disease.
Onishi C; Ohashi K; Sawada T; Nakano M; Kobayashi T; Yamashita T; Akiyama H; Sakamaki H
Int J Hematol; 2010 Apr; 91(3):464-70. PubMed ID: 20217287
[TBL] [Abstract][Full Text] [Related]
42. Osteonecrosis of the hip in patients with aplastic anemia.
Park J; Jun J; Kim Y; Lee J; Kim C; Hahn S
J Korean Med Sci; 2002 Dec; 17(6):806-10. PubMed ID: 12483006
[TBL] [Abstract][Full Text] [Related]
43. Correlation between bone marrow edema and collapse of the femoral head in steroid-induced osteonecrosis.
Iida S; Harada Y; Shimizu K; Sakamoto M; Ikenoue S; Akita T; Kitahara H; Moriya H
AJR Am J Roentgenol; 2000 Mar; 174(3):735-43. PubMed ID: 10701618
[TBL] [Abstract][Full Text] [Related]
44. Osteonecrosis of hip and knee in patients with severe acute respiratory syndrome treated with steroids.
Griffith JF; Antonio GE; Kumta SM; Hui DS; Wong JK; Joynt GM; Wu AK; Cheung AY; Chiu KH; Chan KM; Leung PC; Ahuja AT
Radiology; 2005 Apr; 235(1):168-75. PubMed ID: 15703312
[TBL] [Abstract][Full Text] [Related]
45. Superior GVHD-free, relapse-free survival for G-BM to G-PBSC grafts is associated with higher MDSCs content in allografting for patients with acute leukemia.
Fan Q; Liu H; Liang X; Yang T; Fan Z; Huang F; Ling Y; Liao X; Xuan L; Xu N; Xu X; Ye J; Liu Q
J Hematol Oncol; 2017 Jul; 10(1):135. PubMed ID: 28676100
[TBL] [Abstract][Full Text] [Related]
46. Hip preserving surgery with concentrated autologous bone marrow aspirate transplantation for the treatment of asymptomatic osteonecrosis of the femoral head: retrospective review of clinical and radiological outcomes at 6 years postoperatively.
Tomaru Y; Yoshioka T; Sugaya H; Aoto K; Wada H; Akaogi H; Yamazaki M; Mishima H
BMC Musculoskelet Disord; 2017 Jul; 18(1):292. PubMed ID: 28683795
[TBL] [Abstract][Full Text] [Related]
47. Secondary malignancies after bone marrow transplantation in adults.
Lowsky R; Lipton J; Fyles G; Minden M; Meharchand J; Tejpar I; Atkins H; Sutcliffe S; Messner H
J Clin Oncol; 1994 Oct; 12(10):2187-92. PubMed ID: 7931488
[TBL] [Abstract][Full Text] [Related]
48. [Allogeneic hematopoietic transplantation with stem cells extracted from peripheral blood].
Kusminsky G; Foncuberta MC; Aversa L; Drelichman G; Freigeiro D; Burgos R; Irrazabal C; Gonzalez G; Dictar M; Niborski R; Kohan A; Sanchez Avalos JC
Medicina (B Aires); 2000; 60(2):179-87. PubMed ID: 10962806
[TBL] [Abstract][Full Text] [Related]
49. Cyclosporine as possible prophylaxis for obstructive airways disease after allogeneic bone marrow transplantation.
Payne L; Chan CK; Fyles G; Hyland RH; Bafundi P; Yeung M; Messner H
Chest; 1993 Jul; 104(1):114-8. PubMed ID: 8325051
[TBL] [Abstract][Full Text] [Related]
50. [Indications, technique and risks in bone marrow transplantation in adulthood].
Heyll A; Söhngen D; Minning H; Meckenstock G; Aul C; Schneider W
Praxis (Bern 1994); 1996 Mar; 85(12):378-86. PubMed ID: 8643901
[TBL] [Abstract][Full Text] [Related]
51. Allogeneic unrelated bone marrow transplantation from older donors results in worse prognosis in recipients with aplastic anemia.
Arai Y; Kondo T; Yamazaki H; Takenaka K; Sugita J; Kobayashi T; Ozawa Y; Uchida N; Iwato K; Kobayashi N; Takahashi Y; Ishiyama K; Fukuda T; Ichinohe T; Atsuta Y; Mori T; Teshima T;
Haematologica; 2016 May; 101(5):644-52. PubMed ID: 26858357
[TBL] [Abstract][Full Text] [Related]
52. Current status of bone marrow transplantation.
Bortin MM; Horowitz MM
Clin Transpl; 1989; ():93-104. PubMed ID: 2487630
[TBL] [Abstract][Full Text] [Related]
53. Factors influencing the haematological recovery after allogeneic bone marrow transplantation in leukaemia patients treated with methotrexate-containing GVHD prophylaxis: a single-centre experience.
Hassan HT; Krog C; Stockschläder M; Schleimer B; Zeller W; Krüger W; Erttmann R; Zander AR
Anticancer Res; 1997; 17(1B):589-99. PubMed ID: 9066585
[TBL] [Abstract][Full Text] [Related]
54. Relationship between steroid dosage and osteonecrosis of the femoral head after renal transplantation as measured by magnetic resonance imaging.
Kubo T; Fujioka M; Yamazoe S; Yoshimura N; Oka T; Ushijima Y; Hasegawa Y; Hirasawa Y
Transplant Proc; 1998 Nov; 30(7):3039-40. PubMed ID: 9838339
[No Abstract] [Full Text] [Related]
55. Allogeneic bone marrow transplantation for childhood leukemia following a busulfan and melphalan preparative regimen.
Matsuyama T; Kojima S; Kato K
Bone Marrow Transplant; 1998 Jul; 22(1):21-6. PubMed ID: 9678791
[TBL] [Abstract][Full Text] [Related]
56. [Total hip arthroplasty and femoral head osteonecrosis in renal transplant recipients].
Stromboni M; Menguy F; Hardy P; Leparc JM; Lortat-Jacob A; Benoit J
Rev Chir Orthop Reparatrice Appar Mot; 2002 Sep; 88(5):467-74. PubMed ID: 12399711
[TBL] [Abstract][Full Text] [Related]
57. MRI-detected bone marrow changes within 3 weeks after initiation of high-dose corticosteroid therapy: a possible change preceding the subsequent appearance of low-intensity band in femoral head osteonecrosis.
Kubo Y; Yamamoto T; Motomura G; Tsukamoto N; Karasuyama K; Sonoda K; Hatanaka H; Utsunomiya T; Iwamoto Y
Rheumatol Int; 2015 Nov; 35(11):1909-12. PubMed ID: 26297517
[TBL] [Abstract][Full Text] [Related]
58. Prognostic factors for long-term survival in leukemic marrow recipients with special emphasis on age and prophylaxis for graft-versus-host disease.
Aschan J; Ringdén O
Clin Transplant; 1994 Jun; 8(3 Pt 1):258-70. PubMed ID: 8061365
[TBL] [Abstract][Full Text] [Related]
59. A retrospective comparison of allogeneic peripheral blood stem cell and bone marrow transplantation results from a single center: a focus on the incidence of graft-vs.-host disease and relapse.
Ustün C; Arslan O; Beksaç M; Koç H; Gürman G; Ozçelik T; Yilmaz B; Ilhan O; Akan H; Ozcan M; Demirer T; Uysal A; Konuk N; Arat M; Dilek I; Celebi H; Coskun HS
Biol Blood Marrow Transplant; 1999; 5(1):28-35. PubMed ID: 10232738
[TBL] [Abstract][Full Text] [Related]
60. Allogeneic bone marrow transplantation.
Weiden PL
Crit Rev Clin Lab Sci; 1983; 19(3):173-86. PubMed ID: 6373140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
